0001209191-19-001564.txt : 20190103 0001209191-19-001564.hdr.sgml : 20190103 20190103202737 ACCESSION NUMBER: 0001209191-19-001564 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190102 FILED AS OF DATE: 20190103 DATE AS OF CHANGE: 20190103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SINGLETON J MATTHEW CENTRAL INDEX KEY: 0001243514 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 19508116 MAIL ADDRESS: STREET 1: 286 STANWICH ROAD CITY: GREENWICH STATE: CT ZIP: 06830 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12340 EL CAMINO REAL, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 12340 EL CAMINO REAL, SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-02 0 0001607678 Viking Therapeutics, Inc. VKTX 0001243514 SINGLETON J MATTHEW C/O VIKING THERAPEUTICS, INC. 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 1 0 0 0 Stock Option (Right to Buy) 8.32 2019-01-02 4 A 0 22000 0.00 A 2020-01-02 2029-01-02 Common Stock 22000 22000 D /s/ Michael Morneau, as Attorney-in-Fact 2019-01-03